Potent vasopressor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Autonomic Fibers, Postganglionic Vasomotor System Sympathetic Nervous System Kidney

Organisms5

Rats, Inbred Strains Rats, Wistar Dogs Swine Rats, Sprague-Dawley

Diseases13

Hypotension Shock, Septic Decerebrate State Shock Heart Arrest Adrenal Insufficiency Critical Illness Acidosis Pressure Ulcer Sepsis Acute Kidney Injury Hypertension Postoperative Complications

Chemicals and Drugs32

Vasoconstrictor Agents Ephedrine Ritodrine Vasopressins Mephentermine Phenylephrine Arginine Vasopressin Norepinephrine Etomidate Epinephrine Lypressin Angiotensin II Receptors, Vasopressin Cardiotonic Agents Saralasin Catecholamines Hydrochloric Acid Anesthetics, Intravenous Adrenergic alpha-Antagonists Fentanyl Prazosin Hydrocortisone Propranolol Adrenergic alpha-Agonists Midazolam Receptors, Angiotensin Carbon Dioxide Oxygen Renin Dopamine Antihypertensive Agents Nitric Oxide

Analytical, Diagnostic and Therapeutic Techniques and Equipment27

Anesthesia, Obstetrical Blood Pressure Anesthesia, Spinal Critical Care Cardiopulmonary Resuscitation Resuscitation Fluid Therapy Cesarean Section Cardiac Output Heart Rate Prospective Studies Retrospective Studies Respiration, Artificial Infusions, Intravenous Intensive Care Treatment Outcome Hospital Mortality Monitoring, Physiologic Perfusion Double-Blind Method Injections, Intravenous Severity of Illness Index Drug Therapy, Combination Analysis of Variance Cohort Studies Electric Stimulation Risk Factors

Phenomena and Processes12

Blood Pressure Hemodynamics Vascular Resistance Cardiac Output Vasoconstriction Intracranial Pressure Heart Rate Acid-Base Equilibrium Regional Blood Flow Dose-Response Relationship, Drug Pregnancy Time Factors

Information Science1

Hospital Mortality

Named Groups1

Infant, Newborn

Health Care12

Critical Care Intensive Care Units Prospective Studies Retrospective Studies Intensive Care Treatment Outcome Hospital Mortality Double-Blind Method Severity of Illness Index Analysis of Variance Cohort Studies Risk Factors

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Named Groups Health Care

Vasoconstrictor Agents Ephedrine Hypotension Shock, Septic Ritodrine Vasopressins Mephentermine Anesthesia, Obstetrical Decerebrate State Blood Pressure Phenylephrine Anesthesia, Spinal Arginine Vasopressin Critical Care Shock Norepinephrine Autonomic Fibers, Postganglionic Hemodynamics Etomidate Heart Arrest Cardiopulmonary Resuscitation Resuscitation Epinephrine Adrenal Insufficiency Critical Illness Vasomotor System Vascular Resistance Fluid Therapy Lypressin Angiotensin II Receptors, Vasopressin Acidosis Cesarean Section Cardiac Output Vasoconstriction Pressure Ulcer Cardiotonic Agents Intracranial Pressure Saralasin Catecholamines Heart Rate Intensive Care Units Prospective Studies Sepsis Hydrochloric Acid Anesthetics, Intravenous Adrenergic alpha-Antagonists Retrospective Studies Acid-Base Equilibrium Respiration, Artificial Fentanyl Rats, Inbred Strains Prazosin Infusions, Intravenous Intensive Care Sympathetic Nervous System Treatment Outcome Hydrocortisone Propranolol Acute Kidney Injury Adrenergic alpha-Agonists Midazolam Receptors, Angiotensin Regional Blood Flow Dose-Response Relationship, Drug Hospital Mortality Hypertension Monitoring, Physiologic Rats, Wistar Carbon Dioxide Dogs Perfusion Postoperative Complications Oxygen Renin Dopamine Double-Blind Method Injections, Intravenous Severity of Illness Index Pregnancy Kidney Time Factors Antihypertensive Agents Drug Therapy, Combination Infant, Newborn Swine Nitric Oxide Analysis of Variance Cohort Studies Electric Stimulation Risk Factors Rats, Sprague-Dawley

No FAQ available that match "potent vasopressor"